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Introduction
Takayasu arteritis (TA) is a rare chronic granulomatous
vasculitis of large vessels. Initial symptoms and signs are
usually non-specific, therefore a high index of suspicion
is needed to make a timely and correct diagnosis.
Objectives
To review our experience with treatment of children
with TA.
Methods
We analysed patients data.
Results
In our centre we are currently treating two adolescents
with TA. Patient 1 presented with arthralgia, anaemia and
fatigue. Patient 2 demonstrated leg claudication. None of
them had hypertension. In both of them vascular bruits
and elevated inflammatory markers were present. Diagno-
sis was confirmed by magnetic resonance angiography
(MRA). Both patients were initially treated with pulse
methylprednisolone followed by a high dose oral corticos-
teroid in combination with methotrexate. Both patients
achieved transient clinical and laboratory improvement
with decreased inflammatory parameters after initial
treatment. By tapering steroid therapy inflammatory
parameters started to rise. Patient 2 also demonstrated less
palpable leg pulses and persistent leg claudication. Follow-
up MRA imaging demonstrated only partial improvement
with persistent vascular changes in both patients. Because
of incomplete disease control both patients were started
on anti-tumor necrosis factor (TNF) alpha therapy with
infliximab which resulted in good clinical and laboratory
response with decreased inflammatory parameters.
Conclusion
According to our experience anti-TNF alpha therapy
appears to be a successful treatment approach in pediatric
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